NDC 0054-0711

Deferiprone

Deferiprone

Deferiprone is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Deferiprone.

Product ID0054-0711_c4f9e9be-39e7-4940-9cb0-f17772d7e524
NDC0054-0711
Product TypeHuman Prescription Drug
Proprietary NameDeferiprone
Generic NameDeferiprone
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2022-02-08
Marketing CategoryANDA /
Application NumberANDA213239
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameDEFERIPRONE
Active Ingredient Strength1000 mg/1
Pharm ClassesIron Chelating Activity [MoA], Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0054-0711-19

50 TABLET, COATED in 1 BOTTLE (0054-0711-19)
Marketing Start Date2022-02-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Deferiprone" or generic name "Deferiprone"

NDCBrand NameGeneric Name
0054-0576DeferiproneDeferiprone
0054-0711DeferiproneDeferiprone
51672-4196DeferiproneDeferiprone
10122-100FERRIPROXdeferiprone
10122-101FERRIPROXdeferiprone
10122-103FERRIPROXDEFERIPRONE
10122-104FERRIPROXdeferiprone
52609-0006FERRIPROXdeferiprone
52609-0007FERRIPROXdeferiprone
52609-4502FERRIPROXdeferiprone

Trademark Results [Deferiprone]

Mark Image

Registration | Serial
Company
Trademark
Application Date
DEFERIPRONE
DEFERIPRONE
97303966 not registered Live/Pending
Beer, Kenneth
2022-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.